The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2

被引:128
作者
Saito, M
Ishikawa, F
机构
[1] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Lab Mol & Cellular Assembly,Midori Ku, Yokohama, Kanagawa 2268501, Japan
[2] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Lab Cell Cycle Regulat, Kyoto 6068502, Japan
关键词
D O I
10.1074/jbc.M203455200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although mammalian MBD3 contains the mCpG-binding domain (MBD) and is highly homologous with the authentic mCpG-binding protein MBD2, it was reported that the protein does not bind to mCpG specifically. Using recombinant human wild type and mutant MBD3 proteins, we demonstrated that atypical amino acids found in MBD3 MBD, namely, His-30 and Phe-34, are responsible for the inability of MBD3 to bind to mCpG. Interestingly, although H30K/F34Y MBD3 mutant protein binds to mCpG efficiently in vitro, it was not localized at the mCpG-rich pericentromeric regions in mouse cells. We also showed that Y34F MBD2b MBD, which possesses not the mCpG-specific DNA-binding activity but the nonspecific DNA-binding activity, was localized at the pericentromeric regions. These results suggested that the mCpG-specific DNA-binding activity is largely dispensable, and another factor(s) is required for the localization of MBD proteins in vivo. MBD3 was identified as a component of the NuRD/Mi2 complex that shows chromatin remodeling and histone deacetylase activities. We demonstrated that MBD3 MBD is necessary and sufficient for binding to HDAC1 and MTA2, two components of the NuRD/Mi2 complex. It was therefore suggested that mCpG-binding-defective MBD3 has evolutionarily conserved its MBD because of the secondary role played by the MBD in protein-protein interactions.
引用
收藏
页码:35434 / 35439
页数:6
相关论文
共 23 条
[11]  
Nan XS, 1996, MOL CELL BIOL, V16, P414
[12]   DISSECTION OF THE METHYL-CPG BINDING DOMAIN FROM THE CHROMOSOMAL PROTEIN MECP2 [J].
NAN, XS ;
MEEHAN, RR ;
BIRD, A .
NUCLEIC ACIDS RESEARCH, 1993, 21 (21) :4886-4892
[13]   MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex [J].
Ng, HH ;
Zhang, Y ;
Hendrich, B ;
Johnson, CA ;
Turner, BM ;
Erdjument-Bromage, H ;
Tempst, P ;
Reinberg, D ;
Bird, A .
NATURE GENETICS, 1999, 23 (01) :58-61
[14]   Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1 [J].
Ohki, I ;
Shimotake, N ;
Fujita, N ;
Nakao, M ;
Shirakawa, M .
EMBO JOURNAL, 1999, 18 (23) :6653-6661
[15]   Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA [J].
Ohki, I ;
Shimotake, N ;
Fujita, N ;
Jee, JG ;
Ikegami, T ;
Nakao, M ;
Shirakawa, M .
CELL, 2001, 105 (04) :487-497
[16]   Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a [J].
Ramsahoye, BH ;
Biniszkiewicz, D ;
Lyko, F ;
Clark, V ;
Bird, AP ;
Jaenisch, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5237-5242
[17]   The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability [J].
Riccio, A ;
Aaltonen, LA ;
Godwin, AK ;
Loukola, A ;
Percesepe, A ;
Salovaara, R ;
Masciullo, V ;
Genuardi, M ;
Paravatou-Petsotas, M ;
Bassi, DE ;
Ruggeri, BA ;
Klein-Szanto, AJP ;
Testa, JR ;
Neri, G ;
Bellacosa, A .
NATURE GENETICS, 1999, 23 (03) :266-268
[18]   MBD2-MBD3 complex binds to hemi-methylated DNA and forms a complex containing DNMT1 at the replication foci in late S phase [J].
Tatematsu, K ;
Yamazaki, T ;
Ishikawa, F .
GENES TO CELLS, 2000, 5 (08) :677-688
[19]   The 400 kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily [J].
Vassilev, A ;
Yamauchi, J ;
Kotani, T ;
Prives, C ;
Avantaggiati, ML ;
Qin, J ;
Nakatani, Y .
MOLECULAR CELL, 1998, 2 (06) :869-875
[20]   Methyl CpG binding proteins: coupling chromatin architecture to gene regulation [J].
Wade, PA .
ONCOGENE, 2001, 20 (24) :3166-3173